Christine Sacco Net Worth

The estimated Net Worth of Christine Sacco is at least 8.63 百万$ dollars as of 14 February 2024. Ms. Sacco owns over 30,019 units of Prestige Consumer Healthcare Inc stock worth over 1,546,007$ and over the last 8 years she sold PBH stock worth over 5,373,309$. In addition, she makes 1,715,480$ as Chief Financial Officer at Prestige Consumer Healthcare Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Sacco PBH stock SEC Form 4 insiders trading

Christine has made over 2 trades of the Prestige Consumer Healthcare Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she sold 30,019 units of PBH stock worth 2,051,799$ on 14 February 2024.

The largest trade she's ever made was selling 55,294 units of Prestige Consumer Healthcare Inc stock on 24 May 2023 worth over 3,321,511$. On average, Christine trades about 3,413 units every 11 days since 2016. As of 14 February 2024 she still owns at least 21,738 units of Prestige Consumer Healthcare Inc stock.

You can see the complete history of Ms. Sacco stock trades at the bottom of the page.

Christine Sacco biography

Christine Sacco is a Chief Financial Officer of Prestige Brands Holdings Inc. Ms. Sacco joined the Company from Boulder Brands, Inc., where she served as the Chief Financial Officer and Treasurer from January 2012 to January 2016 and Vice President and Controller from January 2008 to January 2012 including Principal Accounting Officer from January 2011 to March 2012. From October 2002 until January 2008, she held positions of increasing financial responsibility with Alpharma, Inc., a global specialty pharma company where she last held the position of Vice President, Treasurer. Ms. Sacco began her career with Ernst & Young and worked for five years in the Audit and Assurance group. She holds a B.S. in accounting from St. Thomas Aquinas College and is a Certified Public Accountant.

What is the salary of Christine Sacco?

As the Chief Financial Officer of Prestige Consumer Healthcare Inc, the total compensation of Christine Sacco at Prestige Consumer Healthcare Inc is 1,715,480$. There are 2 executives at Prestige Consumer Healthcare Inc getting paid more, with Ronald Lombardi having the highest compensation of 5,051,680$.

How old is Christine Sacco?

Christine Sacco is 44, she's been the Chief Financial Officer of Prestige Consumer Healthcare Inc since 2016. There are 15 older and no younger executives at Prestige Consumer Healthcare Inc. The oldest executive at Prestige Consumer Healthcare Inc is James Jenness, 73, who is the Independent Director.

Insiders trading at Prestige Consumer Healthcare Inc

Over the last 20 years, insiders at Prestige Consumer Healthcare Inc have traded over 32,224,266$ worth of Prestige Consumer Healthcare Inc stock and bought 60,410 units worth 1,162,754$ . The most active insiders traders include Matthew Mannelly、James M Jenness、Dawn M. Zier. On average, Prestige Consumer Healthcare Inc executives and independent directors trade stock every 62 days with the average trade being worth of 2,469,571$. The most recent stock trade was executed by Mary Beth Fritz on 1 March 2024, trading 172 units of PBH stock currently worth 6,908$.

What does Prestige Consumer Healthcare Inc do?

at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th

Complete history of Ms. Sacco stock trades at Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc executives and stock owners

Prestige Consumer Healthcare Inc executives and other stock owners filed with the SEC include:

• Ronald Lombardi,
  Chairman of the Board, President, Chief Executive Officer
• Ronald M. Lombardi,
  Chairman, Pres & CEO
• Christine Sacco,
  Chief Financial Officer
• William PPool,
  Senior Vice President, General Counsel and Corporate Secretary
• Adel Mekhail,
  Executive Vice President - Sales and Marketing
• Christine Sacco,
  Chief Financial Officer
• Jeffrey Zerillo,
  Senior Vice President, Operations
• Adel Mekhail,
  Exec. VP of Marketing & Sales
• William C. P'Pool,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Jeffrey Zerillo,
  Sr. VP of Operations
• Gary Costley,
  Lead Independent Director
• John Byom,
  Independent Director
• James Jenness,
  Independent Director
• Natale Ricciardi,
  Independent Director
• Sheila Hopkins,
  Independent Director
• Christopher Coughlin,
  Independent Director
• Dawn Zier,
  Independent Director
• Mary Beth Fritz,
  Sr. VP of Quality & Regulatory Affairs
• Dean Siegal,
  Director of Communications
• Philip David Terpolilli,
  Director of Investor Relations
• John F. Kelly,
  Director
• Lieven Nuyttens,
  Senior VP, Operations
• Partners Viii L Pgtcr Golde...,
  
• Paul Migaki,
  VP Strategic Planning/Canada
• Thomas Hochuli,
  Vice President, Operations
• David S Marberger,
  Chief Financial Officer
• Timothy Connors,
  Chief Marketing Officer
• John Parkinson,
  Senior VP- International
• Christopher Heye,
  See remarks
• Carl J Johnson,
  Director
• Samuel C Cowley,
  General Counsel, VP Bus. Dev.
• James E Kelly,
  Senior VP - Marketing
• Mark Pettie,
  Chairman of the Board and CEO
• Ronald B Gordon,
  Director
• Charles Schrank,
  Senior V.P. of Marketing
• Peter Anderson,
  Chief Financial Officer
• David Talbert,
  Senior Vice President, Sales
• Gerard Butler,
  Chief Sales Officer
• Co Invest Ii Lpgtcr Golder ...,
  
• Fund Viii Lpgtcr Partners V...,
  
• Jean A Boyko,
  SVP, Quality & Reg. Affairs
• John Byom,
  Director
• Eric S. Klee,
  Secretary and General Counsel
• Peter Mann,
  Chief Executive Officer
• L Dick Buell,
  Director
• Mezzanine Partners Lpgtcr P...,
  
• Frank Palantoni,
  President and COO
• Eric Millar,
  Senior V.P. of Operations
• Charles Hinkaty,
  Director
• Matthew Mannelly,
  President and CEO
• Michael Fink,
  Senior V.P. of Marketing
• Raymond Silcock,
  Director
• Paul A. Hennessey,
  Vice President, Operations
• Patrick Lonergan,
  Director
• Vincent J Hemmer,
  Director
• Mezzanine Partners Lpgtcr G...,
  
• Fund Viii/B L Pgtcr Partner...,
  
• Golder Rauner Ii Llc Gtcr,
  10% owner
• Capital Partners L Pgtcr Me...,
  
• David Donnini,
  Director
• Charles Jolly,
  Secretary & General Counsel
• Celeste A. Clark,
  Director
• James D Arecca,
  Director
• William P'pool,
  See Remarks
• Mary Beth Fritz,
  SVP Quality & Regulatory